Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. | Front Immunol | 2022 | 36311791 | PubTator, text mining | PubMed |
| Plants in vitro propagation with its applications in food, pharmaceuticals and cosmetic industries; current scenario and future approaches. | Front Plant Sci | 2022 | 36311115 | PubTator, text mining | PubMed |
| Mendelian randomization accounting for complex correlated horizontal pleiotropy while elucidating shared genetic etiology. | Nat Commun | 2022 | 36310177 | PubTator, text mining | PubMed |
| Subacute Pulmonary Toxicity of Glutaraldehyde Aerosols in a Human In Vitro Airway Tissue Model. | Int J Mol Sci | 2022 | 36292975 | PubTator, text mining | PubMed |
| Fermented Angelicae tenussimae with Aspergillus oryzae Improves Skin Barrier Properties, Moisturizing, and Anti-Inflammatory Responses. | Int J Mol Sci | 2022 | 36292928 | PubTator, text mining | PubMed |
| Keratin Promotes Differentiation of Keratinocytes Seeded on Collagen/Keratin Hydrogels. | Bioengineering (Basel) | 2022 | 36290526 | PubTator, text mining | PubMed |
| Store-operated calcium channels in skin. | Front Physiol | 2022 | 36277201 | PubTator, text mining | PubMed |
| Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line. | Nat Commun | 2022 | 36270990 | PubTator, text mining | PubMed |
| A TNFR1-UBCH10 axis drives lung squamous cell carcinoma dedifferentiation and metastasis through a cell-autonomous signaling loop. | Cell Death Dis | 2022 | 36270982 | PubTator, text mining | PubMed |
| Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives. | Clin Cosmet Investig Dermatol | 2022 | 36267690 | PubTator, text mining | PubMed |
| Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis. | Cell Rep | 2022 | 36261000 | PubTator, text mining | PubMed |
| Corneal epithelium in keratoconus underexpresses active NRF2 and a subset of oxidative stress-related genes. | PLoS One | 2022 | 36240204 | PubTator, text mining | PubMed |
| Xeno-free self-assembling peptide scaffolds for building 3D organotypic skin cultures. | FASEB Bioadv | 2022 | 36238363 | PubTator, text mining | PubMed |
| S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases. | Molecules | 2022 | 36235175 | PubTator, text mining | PubMed |
| The Adhesion G-Protein-Coupled Receptor GPR115/ADGRF4 Regulates Epidermal Differentiation and Associates with Cytoskeletal KRT1. | Cells | 2022 | 36231117 | PubTator, text mining | PubMed |
| Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications. | Int J Womens Dermatol | 2022 | 36225612 | PubTator, text mining | PubMed |
| Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors. | Mol Ther Methods Clin Dev | 2022 | 36212909 | PubTator, text mining | PubMed |
| Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication. | Dermatol Ther | 2022 | 36200594 | PubTator, text mining | PubMed |
| Screening of Plant-Derived Natural Extracts to Identify a Candidate Extract Capable of Enhancing Lipid Synthesis in Keratinocytes. | Ann Dermatol | 2022 | 36198624 | PubTator, text mining | PubMed |
| Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes. | PLoS Pathog | 2022 | 36190982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=24